These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26074699)

  • 1. Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.
    Pichler J; Huber WD; Aufricht C; Bidmon-Fliegenschnee B
    World J Gastroenterol; 2015 Jun; 21(21):6613-20. PubMed ID: 26074699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paediatric patients with inflammatory bowel disease who received infliximab experienced improved growth and bone health.
    Pichler J; Hanslik A; Huber WD; Aufricht C; Bidmon-Fliegenschnee B
    Acta Paediatr; 2014 Feb; 103(2):e69-75. PubMed ID: 24237381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease.
    Walters TD; Faubion WA; Griffiths AM; Baldassano RN; Escher J; Ruemmele FM; Hyams JS; Lazar A; Eichner S; Huang B; Li Y; Thakkar RB
    Inflamm Bowel Dis; 2017 Jun; 23(6):967-975. PubMed ID: 28301428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease.
    Griffin LM; Thayu M; Baldassano RN; DeBoer MD; Zemel BS; Denburg MR; Denson LA; Shults J; Herskovitz R; Long J; Leonard MB
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2630-9. PubMed ID: 25919459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease.
    Fumery M; Jacob A; Sarter H; Michaud L; Spyckerelle C; Mouterde O; Savoye G; Colombel JF; Peyrin-Biroulet L; Gower-Rousseau C; Turck D;
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):744-8. PubMed ID: 26000887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.
    Haas L; Chevalier R; Major BT; Enders F; Kumar S; Tung J
    Dig Dis Sci; 2017 Nov; 62(11):3110-3116. PubMed ID: 28895012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
    Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
    Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for pediatric Crohn's disease].
    Navas-López VM; Pujol Muncunill G; Llerena E; Navalón Rubio M; Gil-Ortega D; Varea-Calderón V; Sierra Salinas C; Martin-de-Carpi J
    An Pediatr (Engl Ed); 2018 Feb; 88(2):89-99. PubMed ID: 28434894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies.
    Bamberger S; Martinez Vinson C; Mohamed D; Viala J; Carel JC; Hugot JP; Simon D
    PLoS One; 2016; 11(9):e0163126. PubMed ID: 27636201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies.
    Martín-de-Carpi J; Pociello N; Varea V
    J Crohns Colitis; 2010 Nov; 4(5):594-8. PubMed ID: 21122566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.
    Nuti F; Civitelli F; Bloise S; Oliva S; Aloi M; Latorre G; Viola F; Cucchiara S
    J Crohns Colitis; 2016 Jan; 10(1):5-12. PubMed ID: 26188350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels.
    Bond A; Asher R; Jackson R; Sager K; Martin K; Kneebone A; Philips S; Taylor W; Subramanian S
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):271-6. PubMed ID: 26657455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
    Diamanti A; Basso MS; Gambarara M; Papadatou B; Bracci F; Noto C; Castro M
    Int J Colorectal Dis; 2009 Jan; 24(1):19-25. PubMed ID: 18797887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
    Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease.
    Assa A; Hartman C; Weiss B; Broide E; Rosenbach Y; Zevit N; Bujanover Y; Shamir R
    J Crohns Colitis; 2013 Jun; 7(5):369-76. PubMed ID: 22483567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease.
    Sinitsky DM; Lemberg DA; Leach ST; Bohane TD; Jackson R; Day AS
    J Gastroenterol Hepatol; 2010 Apr; 25(4):810-6. PubMed ID: 20492339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD).
    Malik S; Ahmed SF; Wilson ML; Shah N; Loganathan S; Naik S; Bourke B; Thomas A; Akobeng AK; Fagbemi A; Wilson DC; Russell RK
    J Crohns Colitis; 2012 Apr; 6(3):337-44. PubMed ID: 22405171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
    Boot AM; Bouquet J; Krenning EP; de Muinck Keizer-Schrama SM
    Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn's disease.
    Yamamoto K; Chiba T; Matsumoto T
    World J Gastroenterol; 2015 Sep; 21(35):10208-14. PubMed ID: 26401086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.